207 related articles for article (PubMed ID: 4921953)
1. The myeloproliferative disorders.
Gilbert HS; Dameshek W
Dis Mon; 1970 Oct; ():1-52. PubMed ID: 4921953
[No Abstract] [Full Text] [Related]
2. [Myeloproliferative disorders].
Binder D; Fehr J
Ther Umsch; 2004 Feb; 61(2):131-42. PubMed ID: 15018396
[TBL] [Abstract][Full Text] [Related]
3. Myeloproliferative syndromes: diagnosis and therapeutic options.
Hellmann A
Pol Arch Med Wewn; 2008 Dec; 118(12):756-60. PubMed ID: 19202955
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of myeloproliferative disorders.
Laszlo J; Huang AT
Curr Probl Cancer; 1977 Jul; 2(1):1-42. PubMed ID: 268266
[No Abstract] [Full Text] [Related]
5. [Chronic myeloproliferative syndromes].
de Ozalla CB; García Suárez J
Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
[No Abstract] [Full Text] [Related]
6. The spectrum of myeloproliferative disorders.
Gilbert HS
Med Clin North Am; 1973 Mar; 57(2):355-93. PubMed ID: 4570933
[No Abstract] [Full Text] [Related]
7. [Diagnosis and therapy of chronic myeloproliferative disorders].
Kimura A
Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):507-12. PubMed ID: 9577584
[No Abstract] [Full Text] [Related]
8. Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives.
Baumeister J; Chatain N; Sofias AM; Lammers T; Koschmieder S
Cells; 2021 Dec; 10(12):. PubMed ID: 34944059
[TBL] [Abstract][Full Text] [Related]
9. Are polycythemia vera, essential thrombocytosis, and primary myelofibrosis 1, 2, or 3 diseases?
Spivak JL
Leukemia; 2021 Jul; 35(7):1890-1893. PubMed ID: 33911177
[No Abstract] [Full Text] [Related]
10. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
Campr V
Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
[TBL] [Abstract][Full Text] [Related]
12. Myeloproliferative Neoplasms.
Spivak JL
N Engl J Med; 2017 Jun; 376(22):2168-2181. PubMed ID: 28564565
[No Abstract] [Full Text] [Related]
13. Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy.
Macdonald D; Cross NC
Pathobiology; 2007; 74(2):81-8. PubMed ID: 17587879
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
Michiels JJ; Thiele J
Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of the myeloproliferative disorders: resolving phenotypic mimicry.
Spivak JL
Semin Hematol; 2003 Jan; 40(1 Suppl 1):1-5. PubMed ID: 12682874
[TBL] [Abstract][Full Text] [Related]
16. [Myeloproliferative syndrome].
Nowotny P; Preussfner S; Konrad H; Engelmann C; Günther I
Z Gesamte Inn Med; 1976 Apr; 31(8):250-4. PubMed ID: 986731
[TBL] [Abstract][Full Text] [Related]
17. The myeloproliferative syndromes.
Penington DG
Med J Aust; 1974 Jul; 2(2):56-64. PubMed ID: 4416373
[No Abstract] [Full Text] [Related]
18. Pediatric Myeloproliferative Neoplasms.
El-Sharkawy F; Margolskee E
Clin Lab Med; 2021 Sep; 41(3):529-540. PubMed ID: 34304780
[TBL] [Abstract][Full Text] [Related]
19. The myelodysplastic syndromes and myeloproliferative disorders.
Williams JL
Clin Lab Sci; 2004; 17(4):223-34. PubMed ID: 15559729
[TBL] [Abstract][Full Text] [Related]
20. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
